Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274).

Abstract

Human Gene TherapyVol. 7, No. 16 News and CommentsTreatment of Advanced Mesothelioma with the Recombinant Adenovirus H5.010RSVTK: A Phase 1 Trial (BB-IND 6274)INVESTIGATORS Joseph Treat, Larry R. Kaiser, Daniel H. Sterman, Leslie Litzky, Alan Davis, James M. Wilson, and Steven M. AlbeldaINVESTIGATORS Joseph TreatSearch for more papers by this author, Larry R. KaiserSearch for more papers by this author, Daniel H. StermanSearch for more papers by this author, Leslie LitzkySearch for more papers by this author, Alan DavisSearch for more papers by this author, James M. WilsonSearch for more papers by this author, and Steven M. AlbeldaSearch for more papers by this authorPublished Online:20 Mar 2008https://doi.org/10.1089/hum.1996.7.16-2047AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byOncolytic Viral Therapy for Mesothelioma24 August 2017 | Frontiers in Oncology, Vol. 7Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study9 September 2011 | Cancer Gene Therapy, Vol. 18, No. 12Gene Therapy for Malignant Pleural Mesothelioma26 June 2010Pleura and Peritoneum15 October 2007Gene Therapy for Malignant Pleural MesotheliomaHematology/Oncology Clinics of North America, Vol. 19, No. 6Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy20 October 2005 | Clinical Cancer Research, Vol. 11, No. 20Gene Therapy for Malignant Pleural MesotheliomaDevelopment of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancerUrology, Vol. 63, No. 3Gene Therapy for Malignant Mesothelioma25 June 2013Gene Transfer to the Pleural Mesothelium as a Strategy to Deliver Proteins to the Lung Parenchyma Masahiro Mae and Ronald G. Crystal6 July 2004 | Human Gene Therapy, Vol. 13, No. 12Molekulare Pathologie bösartiger pulmonaler und pleuraler TumorenPreemptive and Therapeutic Uses of Suicide Genes for Cancer and LeukemiaTreatment of Mesothelioma Using Adenoviral-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Gene in Combination with GanciclovirManagement of malignant pleural effusions1 August 2001 | European Respiratory Journal, Vol. 18, No. 2Biological Considerations in Lung CancerTreatment of Mesotheliomatous Pleural EffusionJournal of Bronchology, Vol. 8, No. 1Management of Malignant Pleural EffusionsAmerican Journal of Respiratory and Critical Care Medicine, Vol. 162, No. 5Genetic Targeting of Adenoviral VectorsMolecular Therapy, Vol. 1, No. 5Gene Therapy for Lung CancerClinical Lung Cancer, Vol. 1, No. 3CYTOTOXICITY OF ADENOVIRAL-MEDIATED CYTOSINE DEAMINASE PLUS 5-FLUOROCYTOSINE GENE THERAPY IS SUPERIOR TO THYMIDINE KINASE PLUS ACYCLOVIR IN A HUMAN RENAL CELL CARCINOMA MODELJournal of Urology, Vol. 162, No. 3 Part 1Advances in the Treatment of Malignant Pleural MesotheliomaChest, Vol. 116, No. 2MesotheliomaImpact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma Katherine L. Molnar-Kimber, Daniel H. Sterman, Michael Chang, Eugen H. Kang, Mohammed ElBash, Michael Lanuti, Ashraf Elshami, Karen Gelfand, James M. Wilson, Larry R. Kaiser, and Steven M. Albelda20 March 2008 | Human Gene Therapy, Vol. 9, No. 14Antitumor Activity with the HSV-tk-gene-modified Cell Line PA-1-STK in Malignant MesotheliomaAmerican Journal of Respiratory Cell and Molecular Biology, Vol. 19, No. 2GENE THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMAHematology/Oncology Clinics of North America, Vol. 12, No. 3GENE THERAPY FOR LUNG CANCERHematology/Oncology Clinics of North America, Vol. 12, No. 3Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malignant Mesothelioma Daniel H. Sterman, Joseph Treat, Leslie A. Litzky, Kunjlata M. Amin, Laura Coonrod, Katherine Molnar-Kimber, Adri Recio, Linda Knox, James M. Wilson, Steven M. Albelda, and Larry R. Kaiser20 March 2008 | Human Gene Therapy, Vol. 9, No. 7 Volume 7Issue 16Oct 1996 InformationCopyright 1996, Mary Ann Liebert, Inc.To cite this article:INVESTIGATORS Joseph Treat, Larry R. Kaiser, Daniel H. Sterman, Leslie Litzky, Alan Davis, James M. Wilson, and Steven M. Albelda.Treatment of Advanced Mesothelioma with the Recombinant Adenovirus H5.010RSVTK: A Phase 1 Trial (BB-IND 6274).Human Gene Therapy.Oct 1996.2047-2057.http://doi.org/10.1089/hum.1996.7.16-2047Published in Volume: 7 Issue 16: March 20, 2008PDF download